Paid Clinical Trials in Fort Lauderdale, FL
As of August 2026, 156 paid clinical trials are recruiting in Fort Lauderdale, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fort Lauderdale offers studies at sites including Holy Cross Hospital for conditions such as Amblyopia, Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer, Carcinoma, Non-Small-Cell Lung. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fort Lauderdale
Trials by drug in Fort Lauderdale
Filter results
Newly added in Fort Lauderdale
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
151 clinical trials
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Assessment of CCM in HF With Higher Ejection Fraction
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Pelacarsen Roll-over Extension Program
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Top Research Study Locations in Fort Lauderdale
Researchers run research studies in Fort Lauderdale, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Holy Cross Hospital | Breast Cancer, Stage IIIB Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 40 |
| Broward Health Medical Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8 | 23 |
| Nova Southeastern University | ALS, Alveolar Ridge Preservation, Anxiety | 7 |
| Holy Cross Health | Acute Stroke, Cancer, Early Breast Cancer | 3 |
| Proactive Clinical Research | Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Chronic Idiopathic Constipation (CIC) | 3 |
| Retina Group of Florida | Age-related Macular Degeneration (AMD), Geographic Atrophy, Geographic Atrophy (GA) | 3 |
| The Center for Diabetes and Endocrine Care | Cortisol Excess, Graves Disease, Graves' Disease | 3 |
| Broward Health | Diastolic Heart Failure, Heart Failure, Heart Failure With Mid Range Ejection Fraction | 2 |
| CAN Community Health Fort Lauderdale | HIV Infections, HIV-1-infection | 2 |
| Florida Kidney Physicians, LLC - Fort Lauderdale | Focal Segmental Glomerulosclerosis, Proteinuric Kidney Diseases | 2 |
| GSK Investigational Site | HIV Infections, Pulmonary Disease, Chronic Obstructive | 2 |
| Helios Clinical Research | Advanced Non-Small Cell Lung Cancer, Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma | 2 |
| Nova Southeastern University College of Optometry | Amblyopia, Dry Age Related Macular Degeneration, Epiretinal Membrane | 2 |
| Nova Southeastern University College of Optometry, The Eye Institute | Amblyopia | 2 |
| Proactive Clinical Research,LLC | COVID-19 SARS-CoV-2 Infection, Clostridioides Difficile Associated Disease | 2 |
| Retina Group of Florida (Ft. Lauderdale) | Macular Edema Secondary to Inflammation | 2 |
| Retina Group of Florida - Fort Lauderdale | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 2 |
| The Eye Care Institute | Congenital Coloboma of the Optic Nerve, Glaucoma, Suspect, Healthy Eyes | 2 |
| The Oncology Institute of Hope and Innovation | NSCLC Stage IV, Small Cell Lung Cancer | 2 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Adverum | Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD | 1 |
| American Arthritis and Rheumatology Associates LLC | Rheumatoid Arthritis | 1 |
| Broward Health Imperial Point | Cervical Cancer | 1 |
| Broward Health Medical Center & The University of Florida | Alzheimer Disease | 1 |
| Cantor Spine Center | Back Pain Lower Back, Verteborgenic Low Back Pain | 1 |
Active & Upcoming Studies in Fort Lauderdale (2026)
Recruiting trials in Fort Lauderdale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (61 active studies)
- Study Evaluating Safety, Tolerability, and Metabolism of Niraparib · Phase 4 · University of Miami
- Family Communications After Genetic Testing · Alliance for Clinical Trials in Oncology
Eye & vision (13 active studies)
- Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration · Phase 2 · Adverum Biotechnologies, Inc.
- Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study · Phase 3 · Ocular Therapeutix, Inc.
Cardiovascular (10 active studies)
- ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety) · Emory University
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Neurology & pain (4 active studies)
- A Prospective Cohort Study of Basivertebral Nerve Ablation Using the Stryker OptaBlate BVN System for the Treatment of Vertebrogenic Low Back Pain · Stryker Instruments
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) · Phase 2, Phase 3 · DiaMedica Therapeutics Inc
HIV / STI (3 active studies)
- Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy · Phase 3 · Gilead Sciences
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
Vaccines (2 active studies)
Diabetes & metabolic (2 active studies)
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) · Phase 2 · Sparrow Pharmaceuticals
- Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease · Phase 3 · Prokidney
Mental health & behavior (1 active study)
- The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program · Nova Southeastern University
Common conditions studied in Fort Lauderdale
- Amblyopia (3 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (3 active studies)
- Breast Cancer (3 active studies)
- Carcinoma, Non-Small-Cell Lung (3 active studies)
- Heart Failure (3 active studies)
- Malignant Solid Neoplasm (3 active studies)
Leading research sponsors in Fort Lauderdale
- National Cancer Institute (NCI)
- Nova Southeastern University
- SWOG Cancer Research Network
- Alliance for Clinical Trials in Oncology
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Fort Lauderdale?
There are approximately 156 recruiting clinical trials in Fort Lauderdale, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fort Lauderdale pay participants?
Most recruiting trials in Fort Lauderdale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fort Lauderdale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fort Lauderdale?
The most common conditions under active study in Fort Lauderdale include Amblyopia (3), Anatomic Stage IV Breast Cancer AJCC v8 (3), Breast Cancer (3), Carcinoma, Non-Small-Cell Lung (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fort Lauderdale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fort Lauderdale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fort Lauderdale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fort Lauderdale?
Recruiting research sites in Fort Lauderdale include Holy Cross Hospital, Broward Health Medical Center, Nova Southeastern University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fort Lauderdale right now?
The largest active categories in Fort Lauderdale are Cancer & tumors (61), Eye & vision (13), Cardiovascular (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.